SG10201913998YA - Methods of treating tumor metastasis - Google Patents
Methods of treating tumor metastasisInfo
- Publication number
- SG10201913998YA SG10201913998YA SG10201913998YA SG10201913998YA SG10201913998YA SG 10201913998Y A SG10201913998Y A SG 10201913998YA SG 10201913998Y A SG10201913998Y A SG 10201913998YA SG 10201913998Y A SG10201913998Y A SG 10201913998YA SG 10201913998Y A SG10201913998Y A SG 10201913998YA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- tumor metastasis
- treating tumor
- treating
- metastasis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762536949P | 2017-07-25 | 2017-07-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201913998YA true SG10201913998YA (en) | 2020-03-30 |
Family
ID=65039860
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201913251VA SG11201913251VA (en) | 2017-07-25 | 2018-07-25 | Methods of treating tumor metastasis |
| SG10201913998YA SG10201913998YA (en) | 2017-07-25 | 2018-07-25 | Methods of treating tumor metastasis |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201913251VA SG11201913251VA (en) | 2017-07-25 | 2018-07-25 | Methods of treating tumor metastasis |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10857173B2 (en) |
| EP (1) | EP3658153A4 (en) |
| JP (2) | JP7391009B2 (en) |
| KR (1) | KR102673151B1 (en) |
| CN (1) | CN110944645A (en) |
| AU (1) | AU2018306299B2 (en) |
| BR (1) | BR112020000832A2 (en) |
| CA (1) | CA3071014A1 (en) |
| IL (1) | IL271934A (en) |
| SG (2) | SG11201913251VA (en) |
| WO (1) | WO2019023388A1 (en) |
| ZA (1) | ZA202000097B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3071014A1 (en) | 2017-07-25 | 2019-01-31 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| AU2018366106A1 (en) | 2017-11-08 | 2020-05-14 | Taris Biomedical Llc | Methods of treatment and maintenance therapy for bladder cancer using gemcitabine |
| KR20210039403A (en) | 2018-08-01 | 2021-04-09 | 타리스 바이오메디컬 엘엘씨 | How to treat overactive bladder with trospium |
| CN114728152A (en) * | 2019-11-01 | 2022-07-08 | 达瑞微芯片生物技术公司 | Two-stage microchip drug delivery device and method |
| WO2024092159A1 (en) * | 2022-10-28 | 2024-05-02 | Taris Biomedical Llc | Methods of treating bladder cancer with gemcitabine |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4111203A (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system with means for improving delivery kinetics of system |
| US6171298B1 (en) | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
| DE60219607T2 (en) | 2001-01-09 | 2007-12-27 | Microchips, Inc., Bedford | FLEXIBLE MICROCHIP DEVICES FOR OPHTHALMOLOGICAL AND OTHER APPLICATION |
| US7534241B2 (en) | 2002-09-23 | 2009-05-19 | Microchips, Inc. | Micro-reservoir osmotic release systems and microtube array device |
| AU2003301669B2 (en) | 2002-10-22 | 2009-04-30 | Biomerix Corporation | Method and system for intravesicular delivery of the therapeutic agents |
| US8361490B2 (en) | 2004-09-16 | 2013-01-29 | Theracoat Ltd. | Biocompatible drug delivery apparatus and methods |
| ES2400091T3 (en) | 2005-08-11 | 2013-04-05 | Massachusetts Institute Of Technology | Intravesical drug delivery device and method |
| WO2008013589A2 (en) | 2006-04-24 | 2008-01-31 | Gloucester Pharmaceuticals | Treatment of ras-expressing tumors |
| EP1913962A1 (en) | 2006-10-22 | 2008-04-23 | Ophir Perelson | Expandable medical device for the treatment and prevention of cardiovascular diseases |
| CA2706384C (en) | 2007-12-11 | 2016-05-31 | Massachusetts Institute Of Technology | Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens |
| BRPI0911098A2 (en) | 2008-04-04 | 2015-10-06 | Lipella Pharmaceuticals Inc | liposomal formulation and method for treating overactive bladder. |
| WO2010009335A1 (en) | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
| BRPI0917135A2 (en) | 2008-08-09 | 2015-11-10 | Massachusetts Inst Technology | medical device for extension and retention in a patient's seminal vesicle, ejaculatory duct, prostate or vas deferens, use of a resorbable elastomer, and osmotic pump device. |
| US10543166B2 (en) | 2009-06-26 | 2020-01-28 | Taris Biomedical Llc | Implantable drug delivery devices and methods of making the same |
| US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| HUE053888T2 (en) | 2009-12-17 | 2021-07-28 | Taris Biomedical Llc | Implantable device with intravesical tolerability |
| WO2011089604A2 (en) | 2010-01-20 | 2011-07-28 | Theracoat Ltd | Material and method for treating internal cavities |
| US20110218488A1 (en) | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
| MX343671B (en) | 2010-06-02 | 2016-11-16 | Abraxis Bioscience Llc * | Methods of treating bladder cancer. |
| DK2600800T3 (en) | 2010-08-05 | 2020-11-16 | Taris Biomedical Llc | DEVICE FOR MEDICINE DELIVERY IN AN UNRETERSTENT AND KITS |
| US9457176B2 (en) | 2010-10-06 | 2016-10-04 | Taris Biomedical Llc | Implantable drug delivery device with bladder retention feature |
| US8690840B2 (en) | 2010-10-06 | 2014-04-08 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
| SG10201807622WA (en) | 2010-10-27 | 2018-10-30 | Prometic Pharma Smt Ltd | Compounds and compositions for the treatment of cancer |
| US9775941B2 (en) | 2010-12-10 | 2017-10-03 | Board Of Regents Of The University Of Neb | Hemodialysis catheter with displaceable lumens to disrupt a fibrous sheet |
| US8979797B2 (en) | 2010-12-16 | 2015-03-17 | Ams Research Corporation | High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics |
| WO2012096985A1 (en) | 2011-01-10 | 2012-07-19 | Taris Biomedical, Inc. | Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding |
| JP6043730B2 (en) | 2011-02-04 | 2016-12-14 | タリス バイオメディカル エルエルシー | Implantable device for controlled release of low solubility drugs |
| US20150005595A1 (en) | 2011-12-30 | 2015-01-01 | Kibur Medical, Inc. | Implantable devices and methods for evaluation of active agents |
| CA2868431A1 (en) | 2012-03-29 | 2013-10-03 | Altor Bioscience Corporation | Methods for treating neoplasia |
| US10058688B2 (en) | 2012-05-09 | 2018-08-28 | Massachusetts Institute Of Technology | Medicament, method, and drug delivery device for treatment of ovarian cancer |
| BR112015004110A2 (en) | 2012-08-31 | 2017-07-04 | Taris Biomedical Llc | prostate drug delivery systems and methods |
| SG11201501424SA (en) | 2012-08-31 | 2015-03-30 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin |
| EP2897616A1 (en) | 2012-09-18 | 2015-07-29 | TARIS Biomedical LLC | Drug delivery systems and methods for treatment of bladder voiding dysfunction!and other lower urinary tract disorders by using trospium |
| US10137287B2 (en) | 2013-03-05 | 2018-11-27 | Taris Biomedical Llc | Drug delivery devices and methods for controlled drug release through device orifice |
| RU2669407C2 (en) | 2013-03-15 | 2018-10-11 | ТАРИС Биомедикал ЛЛК | Drug delivery devices and methods for drug delivery |
| CA2903164C (en) | 2013-03-15 | 2024-06-11 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| CA2944480C (en) | 2013-04-10 | 2021-05-18 | Massachusetts Institute Of Technology | Local drug delivery devices and methods for treating cancer |
| EP3035991B1 (en) | 2013-08-19 | 2020-07-08 | TARIS Biomedical LLC | Multi-unit drug delivery devices |
| US20160279399A1 (en) | 2013-11-05 | 2016-09-29 | Taris Biomedical Llc | Osmotic drug delivery devices, kits, and methods |
| KR102338079B1 (en) | 2014-03-06 | 2021-12-09 | 타리스 바이오메디컬 엘엘씨 | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine |
| RU2591946C2 (en) | 2014-06-24 | 2016-07-20 | Владимир Эдуардович Анников | Method of producing gel-like water-containing explosive composition |
| EP3517099B1 (en) | 2014-06-26 | 2022-12-28 | TARIS Biomedical LLC | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems |
| RU2581946C2 (en) | 2014-07-10 | 2016-04-20 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Method of treating bladder cancer |
| JP7425534B2 (en) | 2015-04-23 | 2024-01-31 | タリス バイオメディカル エルエルシー | Drug delivery devices and methods with drug permeable components |
| CA3023274A1 (en) * | 2016-05-06 | 2017-11-09 | Taris Biomedical Llc | Method of treating lower tract urothelial cancer |
| CA3071014A1 (en) | 2017-07-25 | 2019-01-31 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| AU2018366106A1 (en) | 2017-11-08 | 2020-05-14 | Taris Biomedical Llc | Methods of treatment and maintenance therapy for bladder cancer using gemcitabine |
| KR20210039403A (en) | 2018-08-01 | 2021-04-09 | 타리스 바이오메디컬 엘엘씨 | How to treat overactive bladder with trospium |
-
2018
- 2018-07-25 CA CA3071014A patent/CA3071014A1/en active Pending
- 2018-07-25 WO PCT/US2018/043770 patent/WO2019023388A1/en unknown
- 2018-07-25 KR KR1020207004951A patent/KR102673151B1/en active IP Right Grant
- 2018-07-25 JP JP2020503751A patent/JP7391009B2/en active Active
- 2018-07-25 US US16/045,586 patent/US10857173B2/en active Active
- 2018-07-25 BR BR112020000832-0A patent/BR112020000832A2/en unknown
- 2018-07-25 AU AU2018306299A patent/AU2018306299B2/en active Active
- 2018-07-25 SG SG11201913251VA patent/SG11201913251VA/en unknown
- 2018-07-25 CN CN201880049831.4A patent/CN110944645A/en active Pending
- 2018-07-25 SG SG10201913998YA patent/SG10201913998YA/en unknown
- 2018-07-25 EP EP18837468.0A patent/EP3658153A4/en active Pending
-
2020
- 2020-01-07 ZA ZA2020/00097A patent/ZA202000097B/en unknown
- 2020-01-09 IL IL271934A patent/IL271934A/en unknown
- 2020-10-23 US US17/078,789 patent/US11446322B2/en active Active
-
2022
- 2022-08-10 US US17/884,798 patent/US12059428B2/en active Active
- 2022-09-15 JP JP2022146670A patent/JP7520932B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US12059428B2 (en) | 2024-08-13 |
| KR20200032159A (en) | 2020-03-25 |
| KR102673151B1 (en) | 2024-06-05 |
| CN110944645A (en) | 2020-03-31 |
| ZA202000097B (en) | 2023-01-25 |
| CA3071014A1 (en) | 2019-01-31 |
| US20230075819A1 (en) | 2023-03-09 |
| JP7520932B2 (en) | 2024-07-23 |
| US10857173B2 (en) | 2020-12-08 |
| WO2019023388A1 (en) | 2019-01-31 |
| RU2020107714A3 (en) | 2022-03-23 |
| JP2022180457A (en) | 2022-12-06 |
| US20210145856A1 (en) | 2021-05-20 |
| SG11201913251VA (en) | 2020-01-30 |
| RU2020107714A (en) | 2021-08-25 |
| BR112020000832A2 (en) | 2020-07-21 |
| JP2020528895A (en) | 2020-10-01 |
| IL271934A (en) | 2020-02-27 |
| EP3658153A1 (en) | 2020-06-03 |
| AU2018306299A1 (en) | 2020-03-12 |
| EP3658153A4 (en) | 2021-04-21 |
| JP7391009B2 (en) | 2023-12-04 |
| US11446322B2 (en) | 2022-09-20 |
| US20190060344A1 (en) | 2019-02-28 |
| AU2018306299B2 (en) | 2024-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269026A (en) | Methods of treating tumor | |
| IL275663A (en) | Methods of treating cancer | |
| HK1258098A1 (en) | Methods of treating cancer | |
| HK1251408A1 (en) | Methods of treating cancer | |
| IL263925A (en) | Methods of treating ovarian cancer | |
| ZA201804227B (en) | Methods of treating cancer | |
| IL262342A (en) | Methods of treating cancer | |
| IL265697B1 (en) | Treatment of prostate cancer | |
| IL264443A (en) | Methods of treating prostate cancer | |
| IL271934A (en) | Methods of treating tumor metastasis | |
| ZA201808258B (en) | Methods of treating pancreatic cancer | |
| HK1251927A1 (en) | Novel biomarkers and methods of treating cancer | |
| IL272092A (en) | Methods of treating behavior alterations | |
| SG11202010793UA (en) | Methods of treating cancer | |
| IL277981A (en) | Methods of treating cancer | |
| IL274314A (en) | Methods of treating a tumor | |
| SG11202005163PA (en) | Methods of treating cancer | |
| IL281600A (en) | Methods of treating cancer | |
| IL269123A (en) | Methods of treating cancer | |
| GB201510197D0 (en) | Method of treating ovarian cancer | |
| GB201702139D0 (en) | Methods of cancer treatment |